Menu HOME > PAREXEL-INSIGHTS > OPTIMIZING THE CLINICAL DEVELO... OPTIMIZING THE CLINICAL DEVELOPMENT PROCESS WITH SOCIAL, MOBILE, ANALYTICS, AND CLOUD (SMAC) By David Kiger June 15, 2016 This year’s trending topics are sure to raise eyebrows with pharmaceutical industry headlines discussing the use of virtual reality, wearable technologies, and eSource in clinical studies. But will these eyebrow raises translate into real changes in the way we run trials? It has been shown that we often read the headlines without really digesting and implementing the ideas, and one needs only review the Time magazine article “What You Think You Know About The Web Is Wrong”, written by ChartBeat CEO Tony Haile, to see how the web tends to focus more on getting your attention versus inspiring action. Tony explains how on the web a stunning 55% of readers spend fewer than 15 seconds actively on a page. This same phenomenon is easily applied to our industry, and we need to be mindful of how fast the attention seems to wander into the ‘next’ conversation while not realizing the potential value from the current one. So how do we translate attention into action when speaking about Clinical Development Optimization (CDO)? Please register to view this content